{'52WeekChange': None,
 'SandP52WeekChange': None,
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 62.91,
 'askSize': 900,
 'averageDailyVolume10Day': 34662,
 'averageVolume': 23752,
 'averageVolume10days': 34662,
 'beta': None,
 'beta3Year': 0.89,
 'bid': 61.71,
 'bidSize': 800,
 'bookValue': None,
 'category': 'Health',
 'circulatingSupply': None,
 'companyOfficers': [],
 'currency': 'USD',
 'dayHigh': 63.54,
 'dayLow': 62.6201,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': None,
 'enterpriseToRevenue': None,
 'enterpriseValue': None,
 'exDividendDate': None,
 'exchange': 'NGM',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 62.639427,
 'fiftyTwoWeekHigh': 68.02,
 'fiftyTwoWeekLow': 46.9,
 'fiveYearAverageReturn': -0.014099999,
 'fiveYearAvgDividendYield': None,
 'forwardEps': None,
 'forwardPE': None,
 'fromCurrency': None,
 'fundFamily': 'VanEck',
 'fundInceptionDate': 1324339200,
 'gmtOffSetMilliseconds': '-14400000',
 'headSymbol': None,
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': None,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': 'Exchange Traded Fund',
 'logo_url': '',
 'longBusinessSummary': 'The investment seeks to replicate as closely as '
                        'possible, before fees and expenses, the price and '
                        'yield performance of the MVISÂ® US Listed '
                        'Pharmaceutical 25 Index.\n'
                        ' The fund normally invests at least 80% of its total '
                        'assets in securities that comprise the fund&#39;s '
                        'benchmark index. The index includes common stocks and '
                        'depositary receipts of U.S. exchange-listed companies '
                        'in the pharmaceutical industry. Such companies may '
                        'include medium-capitalization companies and foreign '
                        'companies that are listed on a U.S. exchange. It is '
                        'non-diversified.',
 'longName': 'VanEck Vectors Pharmaceutical ETF',
 'market': 'us_market',
 'marketCap': None,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_3588556',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': None,
 'navPrice': 61.45,
 'netIncomeToCommon': None,
 'nextFiscalYearEnd': None,
 'open': 63.54,
 'openInterest': None,
 'payoutRatio': None,
 'pegRatio': None,
 'phone': '800-826-2333',
 'previousClose': 63.4869,
 'priceHint': 2,
 'priceToBook': None,
 'priceToSalesTrailing12Months': None,
 'profitMargins': None,
 'quoteType': 'ETF',
 'regularMarketDayHigh': 63.54,
 'regularMarketDayLow': 62.6201,
 'regularMarketOpen': 63.54,
 'regularMarketPreviousClose': 63.4869,
 'regularMarketPrice': 63.54,
 'regularMarketVolume': 67897,
 'revenueQuarterlyGrowth': None,
 'shortName': 'VanEck Vectors Pharmaceutical E',
 'startDate': None,
 'strikePrice': None,
 'symbol': 'PPH',
 'threeYearAverageReturn': 0.0394,
 'totalAssets': 232659264,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': None,
 'twoHundredDayAverage': 61.190647,
 'underlyingExchangeSymbol': None,
 'underlyingSymbol': None,
 'uuid': '9c221bcf-6628-3b94-bd01-ead1c936decd',
 'volume': 67897,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'yield': 0.0174,
 'ytdReturn': None}